Cholesterol catabolism as a therapeutic target in Mycobacterium tuberculosis
- PMID: 21924910
- PMCID: PMC3205253
- DOI: 10.1016/j.tim.2011.07.009
Cholesterol catabolism as a therapeutic target in Mycobacterium tuberculosis
Abstract
Mycobacterium tuberculosis (Mtb) is an intracellular pathogen that infects 10 million people worldwide and kills 2 million people every year. The uptake and utilization of nutrients by Mtb within the host cell is still poorly understood, although lipids play an important role in Mtb persistence. The recent identification of a large regulon of cholesterol catabolic genes suggests that Mtb can use host sterol for infection and persistence. In this review, we report on recent progress in elucidation of the Mtb cholesterol catabolic reactions and their potential utility as targets for tuberculosis therapeutic agents.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Figures
References
-
- Cole ST, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998;393:537–544. - PubMed
-
- Lamb DC, et al. Lanosterol biosynthesis in the prokaryote Methylococcus capsulatus: insight into the evolution of sterol biosynthesis. Mol Biol Evol. 2007;24:1714–1721. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
